Comment in

• More on Neurologic Features in Severe SARS-CoV-2 Infection.

  Larvie M, Lev MH, Hess CP. Larvie M, et al. N Engl J Med. 2020 Jun 25;382(26):e110. doi: 10.1056/NEJMc2015132. Epub 2020 May 26. N Engl J Med. 2020. PMID: 32453515 No abstract available.
• More on Neurologic Features in Severe SARS-CoV-2 Infection.

  Sarikaya B. Sarikaya B. N Engl J Med. 2020 Jun 25;382(26):e110. doi: 10.1056/NEJMc2015132. Epub 2020 May 26. N Engl J Med. 2020. PMID: 32453516 No abstract available.
• What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.

  Akhvlediani T, Jelcic I, Taba P, Pfausler B, Steiner I, Sellner J. Akhvlediani T, et al. Eur J Neurol. 2020 Nov;27(11):e69-e72. doi: 10.1111/ene.14395. Epub 2020 Jul 24. Eur J Neurol. 2020. PMID: 32526060 Free PMC article. No abstract available.
• Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2.

  Helbok R, Beer R, Löscher W, Boesch S, Reindl M, Hornung R, Schiefecker AJ, Deisenhammer F, Pfausler B. Helbok R, et al. Eur J Neurol. 2020 Sep;27(9):1754-1756. doi: 10.1111/ene.14388. Eur J Neurol. 2020. PMID: 32531083 Free PMC article. No abstract available.